Posted by ABMN Staff on Apr 24th, 2024
StockNews.com started coverage on shares of Evogene (NASDAQ:EVGN – Get Free Report) in a report issued on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock.
Evogene Trading Up 1.5...
More of this article »